Moral Standards for Research in Developing Countries From "Reasonable Availability" to "Fair Benefits"

• Published in: The Hastings Center report Vol. 34; no. 3; pp. 17 - 27
• Main Authors: El Setouhy, Maged, Agbenyega, Tsiri, Anto, Francis, Clerk, Christine Alexandra, Koram, Kwadwo A., English, Michael, Juma, Rashid, Molyneux, Catherine, Peshu, Norbert, Kumwenda, Newton, Mfutso-Bengu, Joseph, Molyneux, Malcolm, Taylor, Terrie, Diarra, Doumbia Aissata, Maiga, Saïbou, Sylla, Mamadou, Youssouf, Dione, Falade, Catherine Olufunke, Gbadegesin, Segun, Lie, Reidar, Mugusi, Ferdinand, Ngassapa, David, Ecuru, Julius, Talisuna, Ambrose, Emanuel, Ezekiel, Grady, Christine, Higgs, Elizabeth, Plowe, Christopher, Sugarman, Jeremy, Wendler, David
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.05.2004; The Hastings Center; Hastings Center
• Subjects: Bioethics; Clinical Trials as Topic - ethics; Developing Countries; Economic benefits; Ethical aspects; Ethics, Research; Fairness; Health Services Accessibility; Hepatitis; Hepatitis A Vaccines; Humans; International aspects; International Cooperation; LDCs; Medical research; Medical service; Medicine, Experimental; Morality; Morals; Prevention; Public health; Research facilities; Research studies; Social Responsibility; Socioeconomics; Thailand; Vaccination; Vaccination and vaccines; Thailand; Health Care and Public Health; Council for International Organizations of Medical Sciences; Analytical Approach; Biomedical and Behavioral Research
• ISSN: 0093-0334; 1552-146X
• DOI: 10.2307/3528416

Commentators have argued that when research conducted in a developing country shows an intervention to be effective, the intervention must be made “reasonably available” to the host population after the trial. But this standard is sometimes too stringent, and sometimes too lenient. It offers a benefit, but not necessarily a fair benefit.